Addus HomeCare: Strong Position Amid An Opportunistic Market
Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target
Addus HomeCare Corporation 2026 Q1 - Results - Earnings Call Presentation
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92
Addus HomeCare Corporation (ADUS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Addus HomeCare Corp (NASDAQ:ADUS) Passes the Caviar Cruise Quality Screen
Citizens Maintains Market Outperform on Addus HomeCare, Lowers Price Target to $142
Addus HomeCare Corporation (ADUS) Q1 2026 Earnings Call Transcript
Addus HomeCare Q1 2026 Earnings Call: Complete Transcript
Addus HomeCare (NASDAQ:ADUS) Q1 2026 Revenue Miss Overshadows Adjusted Earnings Beat
Addus HomeCare Q1 Adj. EPS $1.62 Beats $1.55 Estimate, Sales $363.611M Miss $366.155M Estimate
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $102
Addus HomeCare Details 2026 Priorities as Medicaid Redeterminations Ease at KeyBanc Forum
Addus HomeCare Says Q4 Ended Strong, Sees Solid Q1 Start Despite Weather, Holiday Disruptions
Addus HomeCare to Participate in Upcoming March Investor Conferences
Q4 Earnings Roundup: Addus HomeCare (NASDAQ:ADUS) And The Rest Of The Senior Health, Home Health & Hospice Segment
Addus HomeCare CFO Flags Medicaid Rate Outlook, Gentiva Deal Progress, and M&A Pipeline at Conference
A Look At Addus HomeCare (ADUS) Valuation After Its Strong Fourth Quarter Earnings Beat
Stephens & Co. Maintains Overweight on Addus HomeCare, Lowers Price Target to $135
Addus HomeCare Corp (ADUS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.